Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
7,420.00    35.00 (0.47%)
Bid:
7,425.00
Ask:
7,430.00
Spread: 5.00 (0.067%)
Market Cap: £32.85b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

SID Appointment and Board Committee Changes

10 Apr 2026 11:00

RNS Number : 0137A
Coca-Cola Europacific Partners plc
10 April 2026
 

SENIOR INDEPENDENT DIRECTOR APPOINTMENT AND

CHANGES IN COMPOSITION OF THE BOARD COMMITTEES

 

The Board of Directors of Coca-Cola Europacific Partners plc (CCEP) announces the following changes to the composition of the Board Committees with effect from the conclusion of the Annual General Meeting (AGM) to be held on 28 May 2026:

 

· Mary Harris, Independent Non-executive Director, will be appointed Senior Independent Director;

 

· Nathalie Gaveau, Independent Non-executive Director, will retire as a member of the Environmental, Social and Governance Committee;

 

· Dessi Temperley, Independent Non-executive Director, will be appointed as a member of the Environmental, Social and Governance Committee;

 

· Nicolas Mirzayantz, Independent Non-executive Director, will be appointed as a member of the Nomination Committee and will retire as a member of the Audit Committee;

 

· Mark Price, Independent Non-executive Director, will be appointed as Chairman of the Affiliated Transaction Committee; and

 

· subject to their formal appointment as Independent Non-executive Directors at the AGM:

 

Laurence Debroux and Uvashni Raman will be appointed as members of the Audit Committee;

Laurence Debroux will be appointed as a member of the Remuneration Committee; and

Uvashni Raman will be appointed as a member of the Affiliated Transaction Committee.

 

Following the changes noted above, the membership of the Committees will be as follows:

 

Audit Committee

Affiliated Transaction Committee

Environmental, Social and Governance Committee

Dessi Temperley (Chairman)

Mark Price (Chairman)

Mario Rotllant (Chairman)

Robert Appleby

Sol Daurella

Robert Appleby

John Bryant

Nathalie Gaveau

Nicolas Mirzayantz

Laurence Debroux

Alfonso Líbano Daurella

Dessi Temperley

Uvashni Raman

Uvashni Raman

Nancy Quan

   

Nomination Committee

Remuneration Committee

Mary Harris (Chairman)

John Bryant (Chairman)

Manolo Arroyo

Manolo Arroyo

Sol Daurella

José Ignacio Comenge

Nicolas Mirzayantz

Laurence Debroux

Mark Price

Mary Harris

 

This notification is made in accordance with UK Listing Rule 6.4.6R(3).

 

CONTACTS

 

Company Secretariat

Svetlana Walker

svetlana.walker@ccep.com

Investor Relations

Sarah Willett

sarah.willett@ccep.com

Media Relations

Shanna Wendt

mediaenquiries@ccep.com

 

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock Exchange and on the Spanish Stock Exchanges, and a constituent of both the NASDAQ 100 and FTSE 100 indices, trading under the symbol CCEP (ISIN No. GB00BDCPN049).

For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEANLEFENKEEA
Date   Source Headline
23rd Feb 20247:00 amRNSPreliminary Unaudited Results Q4 & FY 2023
21st Feb 20245:00 pmRNSDirector/PDMR Shareholding
1st Feb 20242:30 pmRNSTotal Voting Rights
30th Jan 202411:30 amRNSPCC approval received to jointly acquire CCBPI
26th Jan 20244:15 pmRNSDirector/PDMR Shareholding - amendment
25th Jan 202410:30 amRNSDirector/PDMR Shareholding
22nd Jan 20243:15 pmRNSDirector/PDMR Shareholding
17th Jan 202411:30 amRNSDirector/PDMR Shareholding
2nd Jan 20241:30 pmRNSTotal Voting Rights
20th Dec 202311:15 amRNSDirector/PDMR Shareholding
18th Dec 202312:15 pmRNSDirector/PDMR Shareholding
15th Dec 20233:40 pmRNSDirector/PDMR Shareholding
14th Dec 202311:00 amRNSDirectorate Change
1st Dec 20231:45 pmRNSTotal Voting Rights
28th Nov 20234:00 pmRNSDirector/PDMR Shareholding
24th Nov 20232:30 pmRNSUpdate statement on 2023 AGM voting results
21st Nov 20234:30 pmRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSUpdate re acquisition of CCBPI
1st Nov 20231:45 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSQ3 Trading Update & Interim Dividend Declaration
25th Oct 20231:30 pmRNSDirector/PDMR Shareholding
20th Oct 202312:00 pmRNSDirector/PDMR Shareholding
13th Oct 20232:30 pmRNSDirector/PDMR Shareholding
20th Sep 20234:45 pmRNSDirector/PDMR Shareholding
18th Sep 20234:50 pmRNSBlock listing Interim Review
1st Sep 20231:30 pmRNSTotal Voting Rights
22nd Aug 20233:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:01 amRNSResults for the six months ended 30 June 2023
2nd Aug 20237:00 amRNSProposed joint acquisition of CCBPI
1st Aug 20231:05 pmRNSTotal Voting Rights
25th Jul 20234:00 pmRNSDirector/PDMR Shareholding
21st Jul 20232:30 pmRNSDirector/PDMR Shareholding
13th Jul 20233:30 pmRNSDirector/PDMR Shareholding
30th Jun 20234:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20233:00 pmRNSDirector/PDMR Shareholding
8th Jun 202310:50 amRNSDirector/PDMR Shareholding
1st Jun 20232:15 pmRNSTotal Voting Rights
26th May 20234:30 pmRNSDirector/PDMR Shareholding
25th May 202311:30 amRNSResult of AGM
23rd May 20233:00 pmRNSDirector/PDMR Shareholding
18th May 202311:30 amRNSDirector/PDMR Shareholding
15th May 20233:30 pmRNSLetter to Shareholders
4th May 20234:00 pmRNSDirector/PDMR Shareholding
2nd May 20232:45 pmRNSTotal Voting Rights
25th Apr 20237:00 amRNSQ1 Trading Update & Interim Dividend Declaration
21st Apr 20234:58 pmRNSDirector/PDMR Shareholding
14th Apr 20231:30 pmRNSDirector/PDMR Shareholding
12th Apr 20239:00 amRNSNotice of AGM
3rd Apr 20232:45 pmRNSTotal Voting Rights
22nd Mar 202311:45 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.